Disposable Ureteroscope Market Size & Share 2026-2035

Disposable Ureteroscope Market Size

The global disposable ureteroscope market was valued at USD 310.1 million in 2025. The market is expected to grow from USD 364.2 million in 2026 to USD 1.3 billion in 2035, growing at a CAGR of 15.6% during the forecast period, according to the latest report published by Global Market Insights Inc.

Disposable ureteroscopy refers to the performance of ureteroscopy using a single-use ureteroscope, a flexible or semi-rigid endoscopic device designed to visualize and treat conditions of the ureters and kidneys. These devices incorporate imaging and maneuverability features that enable urologists to diagnose and manage conditions such as kidney stones, strictures, and tumors, while minimizing cross-contamination risks and eliminating reprocessing requirements.

The major players in the market are Boston Scientific, Ambu, OLYMPUS, Karl Storz and Dornier MedTech. These companies maintain their competitive position through ongoing product innovation, global market presence, and substantial investment in research and development.

The market has increased from USD 189.1 million in 2022 and reached to USD 262.5 million in 2024, with a historic growth rate of 17.8%. The market growth was driven the rising prevalence of urolithiasis, increasing preference for single-use devices to minimize cross-contamination risks, growing adoption of minimally invasive urological procedures, and the elimination of reprocessing costs and maintenance associated with reusable ureteroscopes.

Moreover, the increasing prevalence of gastrointestinal disorders, such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and gastrointestinal cancers, is contributing to the rising demand for diagnostic procedures globally. For instance, according to 2022 estimates by the European Federation of Crohn’s & Ulcerative Colitis Associations, IBD affects up to 10 million people worldwide. These conditions often require endoscopic examinations for accurate diagnosis and ongoing management. As the burden of gastrointestinal disorders increases, the demand for reliable and safe diagnostic tools continues to grow.

Additionally, minimally invasive procedures, including those performed with disposable ureteroscopes, are associated with a lower risk of complications such as infections and postoperative pain. The single-use nature of disposable ureteroscopes eliminates the risk of cross-contamination and device-related infections, enhancing patient safety. The emphasis on reducing procedural risks and improving patient outcomes is a significant factor driving the adoption of disposable ureteroscopes in minimally invasive endoscopy procedures.

Disposable Ureteroscope Market Trends

• The market is experiencing substantial growth, driven by technological advancements that enhance diagnostic and therapeutic capabilities, improve patient safety, and streamline clinical workflows, thereby accelerating the adoption of disposable ureteroscopes in urological practice.
• Further, advances in imaging technologies have significantly improved visualization capabilities, with high-definition cameras and advanced optics enabling clearer and more detailed views of the urinary tract, supporting accurate diagnosis and precise treatment.
• Improved visualization facilitates better detection of abnormalities such as stones, strictures, and tumors, leading to enhanced clinical outcomes and increased demand for technologically advanced disposable ureteroscopes.
• In addition, innovations in device design have enhanced flexibility and maneuverability, allowing urologists to navigate the complex anatomy of the urinary tract with greater precision while minimizing the risk of tissue injury.
• These capabilities are particularly valuable in complex procedures involving hard-to-reach areas, improving procedural efficiency and safety, and further supporting market growth.

Disposable Ureteroscope Market Analysis

Based on product, the market is segmented into flexible ureteroscope and rigid ureteroscope. The flexible ureteroscope segment dominated the market, accounting for a significant market share of 81.9% in 2025, driven by its widespread clinical adoption, superior maneuverability, and expanding role in minimally invasive urological procedures. The segment is expected to exceed USD 1.1 billion by 2035, growing at a CAGR of 15.5% during the forecast period.

• The dominance of disposable flexible ureteroscopes is primarily attributed to their ability to provide enhanced visualization and access across complex renal anatomy, making them the preferred choice for endourological interventions such as ureteroscopy and retrograde intrarenal surgery (RIRS).
• As urology practices increasingly emphasize infection prevention, procedural efficiency, and consistent performance, single‑use flexible ureteroscopes have gained substantial traction in both hospital and ambulatory surgical settings.

• Additionally, the inherent flexibility of these ureteroscopes allows for easy navigation through the complex and delicate anatomy of the urinary tract. Flexible ureteroscopes can access hard-to-reach areas, making them suitable for a wide range of diagnostic and therapeutic interventions. Their ability to perform complex procedures with minimal trauma to surrounding tissues makes them a preferred choice for urologists, reinforcing their dominant market position.
• The rigid ureteroscope segment accounted for 18.2% share of the disposable ureteroscope market in 2025 and is expected to witness steady growth over the forecast period. The segment’s growth is supported by its continued use in distal ureteral procedures, straightforward diagnostic evaluations, and stone extraction cases.

Based on application, the disposable ureteroscope market is classified into urolithiasis, urethral stricture, kidney cancer, and other applications. The urolithiasis segment accounted for the highest market share and was valued at USD 145.6 million in 2025.

• Urolithiasis, or kidney stones, is a common urological condition affecting millions of people worldwide. For instance, according to a 2022 article by BMC Urology, kidney stone is a major cause of morbidity and affects approximately 1–15% of the world's population.
• The rising prevalence of factors such as obesity, diabetes, and dietary habits contribute to the increasing incidence of kidney stones. As a result, the need for effective diagnostic and therapeutic tools for urolithiasis management has surged.
• Additionally, disposable ureteroscopes are highly effective in diagnosing and treating urolithiasis. Their advanced imaging capabilities allow for precise visualization of stones within the urinary tract, facilitating accurate diagnosis.
• The urethral stricture segment accounted for significant revenue in 2025 and is projected to grow at a CAGR of 15.3% over the forecast period. Growth is driven by the increasing prevalence of urethral strictures associated with trauma, recurrent urinary tract infections, prolonged catheterization, and post-surgical complications, particularly among ageing male populations.
• The kidney cancer segment also accounted for significant revenue in 2025 and is projected to grow at a CAGR of 15.5% over the forecast period. The segmental growth is supported by the rising incidence of renal and upper tract urothelial malignancies, increasing adoption of early diagnostic techniques, and the growing use of minimally invasive endourological procedures for tumor evaluation and management.

• Hospitals perform a high volume of urological procedures, including diagnostics, stone removal, and treatment of urinary tract conditions, creating strong demand for efficient, reliable, and safe medical devices. Disposable ureteroscopes address these needs through consistent performance and reduced risk of cross-contamination.
• In addition, hospitals are equipped with advanced medical infrastructure, including specialized urology departments and modern surgical suites, enabling the effective adoption of technologically advanced devices. This capability supports the performance of complex procedures and reinforces their leading position in the market.
• The ambulatory surgical centers segment accounted for significant revenue of USD 101.3 million in 2025 and is projected to grow steadily over the forecast period. Growth is driven by the increasing shift of urological procedures to outpatient settings, supported by advancements in minimally invasive techniques and reduced recovery times.

North America Disposable Ureteroscope Market

North America dominated the global disposable ureteroscope industry with the highest share of 38.7% in 2025.

• The U.S. disposable ureteroscope industry was valued at USD 69.2 million and USD 82 million in 2022 and 2023, respectively. The market size reached USD 111.9 million in 2025, growing from USD 95.2 million in 2024, and is anticipated to grow at a CAGR of 15% from 2026 to 2035.
• North America represents a dominant share in the market, driven by a high prevalence of urological disorders such as kidney stones, urinary tract infections, urethral strictures, and renal malignancies. The growing incidence of these conditions necessitates frequent endoscopic interventions, significantly increasing procedural volumes across hospitals and ambulatory surgical centers. This high disease burden strongly supports sustained demand for disposable ureteroscopes in the region.
• The region benefits from advanced healthcare infrastructure, high healthcare expenditure, and a strong clinical preference for minimally invasive procedures. Healthcare providers increasingly favor disposable ureteroscopes to reduce procedure turnaround time and ensure consistent optical performance. In addition, the U.S. healthcare system’s strong emphasis on infection control and patient safety has accelerated the adoption of single‑use devices, as they eliminate cross‑contamination risks associated with reusable scopes.
• North America is home to several leading medical device manufacturers that actively invest in product innovation, clinical validation, and commercialization of disposable endourology devices. Continuous technological advancements, combined with favorable reimbursement policies and well‑established distribution networks, improve product accessibility and adoption. These factors collectively reinforce the region’s leadership position in the global disposable ureteroscope market.

Europe Disposable Ureteroscope Market

Europe disposable ureteroscope industry accounted for USD 92.5 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Europe represents a significant share of the disposable ureteroscope industry, supported by well-established healthcare systems, high standards of patient care, and broad access to advanced urological services. The region also faces a growing burden of urological conditions, including kidney stones, urinary tract infections, urethral strictures, and urological cancers, driving demand for endoscopic procedures.
• This trend is evident in countries such as Germany, where an ageing population and the rising incidence of kidney stones and bladder cancer are increasing the need for effective diagnostic and minimally invasive treatment solutions.
• A strong focus on technological innovation, high healthcare expenditure, and stringent infection control regulations further supports market growth across the region.
• In Germany, healthcare providers increasingly prefer single-use ureteroscopes to meet strict hygiene standards, reduce reprocessing-related infection risks, and ensure consistent procedural performance. Additionally, the region’s preference for minimally invasive approaches and early adoption of advanced technologies reinforces Europe’s position as a key market.

Asia Pacific Disposable Ureteroscope Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 16.8% during the analysis timeframe, driven by rising urological disease burden, improving healthcare infrastructure, and increasing adoption of minimally invasive procedures across the region.

• Countries such as Japan are at the forefront of this growth, supported by a high prevalence of urological disorders including nephrolithiasis and urinary tract infections, which require frequent diagnostic and therapeutic uretheroscopic interventions.
• Japan exemplifies the region’s strong emphasis on patient safety, infection control, and technological innovation. The country’s healthcare system actively promotes the use of disposable medical devices to minimize cross‑contamination risks and ensure consistent procedural outcomes.
• Additionally, Japan’s robust medical technology ecosystem, coupled with government support and favorable reimbursement policies, ensures the availability and clinical uptake of high‑quality disposable ureteroscopes. These factors collectively strengthen Asia Pacific’s position as the fastest‑growing regional market

Latin America Disposable Ureteroscope Market

The Latin America market is experiencing robust growth over the analysis timeframe.

• The disposable ureteroscope market in Latin America is supported by the steady expansion of the private healthcare sector and increasing investment in advanced urology services.
• Private hospitals and specialty urology centers across the region are adopting modern endoscopic technologies to improve procedural outcomes and attract patients seeking high‑quality care. This trend is driving the uptake of disposable ureteroscopes, particularly for minimally invasive procedures related to kidney stones, urinary tract infections, and urethral disorders.
• Several countries in the region are strengthening infection control practices and expanding access to minimally invasive surgical care, particularly in urban healthcare facilities. Growing awareness of reprocessing‑related infection risks, coupled with limited sterilization infrastructure in certain settings, is encouraging the use of single‑use ureteroscopes.
• Additionally, improvements in outpatient surgical capacity and gradual modernization of healthcare infrastructure are increasing procedural volumes, supporting continued adoption of disposable ureteroscopes across Latin America.

Middle East and Africa Disposable Ureteroscope Market

The Middle East and Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• Countries across the Middle East are witnessing a rising prevalence of urological conditions due to lifestyle‑related factors such as obesity, diabetes, and metabolic disorders, which increase the incidence of kidney stones and urinary tract complications.
• These conditions necessitate frequent diagnostic and therapeutic endoscopic procedures, driving demand for disposable ureteroscopes. Healthcare providers are increasingly favoring minimally invasive urology solutions to improve patient outcomes and reduce hospital stays.
• Gulf Cooperation Council (GCC) countries are making substantial investments in expanding and modernizing healthcare infrastructure, including new hospitals, specialty urology centers, and advanced surgical facilities.
• These developments are enabling broader access to state‑of‑the‑art endourology technologies, including disposable ureteroscopes. In addition, heightened focus on infection control, limited scope reprocessing capabilities in certain facilities, and the growing adoption of single‑use medical devices are supporting market growth across the region.

Disposable Ureteroscope Market Share

The global disposable ureteroscope industry is characterized by intense competition among established medical device manufacturers, driven by rapid technological innovation, expanding single‑use product portfolios, and increasing emphasis on infection control and procedural efficiency. Market players are actively focusing on the development of high‑resolution digital imaging, improved maneuverability, enhanced durability, and ergonomically optimized single‑use ureteroscopes to address evolving clinical requirements in minimally invasive urology.

Key players such as Boston Scientific, Ambu, Olympus, Karl Storz, and Dornier MedTech collectively account for ~63% of the global disposable ureteroscope market share. These companies benefit from strong brand recognition, extensive global distribution networks, and continuous investments in research and development to enhance optical quality, scope performance, and workflow integration. Strategic initiatives including product launches, portfolio expansion into single‑use solutions, and collaborations with healthcare providers further strengthen their competitive positioning. In addition to the leading players, several regional and emerging manufacturers contribute to market competition by offering cost‑effective disposable ureteroscopes and targeting niche clinical applications or price‑sensitive markets. Favorable regulatory pathways, rising adoption of single‑use endoscopic devices, and expanding healthcare infrastructure in emerging economies are encouraging new entrants to participate in the market. As infection prevention and minimally invasive urology continue to gain priority globally, competition is expected to intensify with a strong focus on innovation, affordability, and consistent clinical performance.

Disposable Ureteroscope Market Companies

A few of the prominent players operating in the disposable ureteroscope industry include:

• Ambu
• Becton, Dickinson and Company
• Boston Scientific
• Coloplast 
• Cook Medical
• Dornier MedTech
• Karl Storz
• NeoScope
• OLYMPUS
• OPCOM Medical
• OTU Medical
• Richard Wolf
• STERIS
• Zhuhai Pusen Medical Technology
   
• OLYMPUS

Olympus holds a strong position in the disposable ureteroscope market by leveraging its deep expertise in endourology and advanced imaging technologies. The company emphasizes high‑quality visualization, ergonomic scope design, and consistent optical performance to support complex ureteroscopic procedures.

• Karl Storz

Karl Storz differentiates itself in the disposable ureteroscope market through precision engineering, superior optics, and a strong clinical reputation in minimally invasive urology. The company focuses on delivering reliable single‑use ureteroscopes that ensure consistent performance while addressing infection control concerns associated with reusable devices.

• Dornier MedTech

Dornier MedTech is a specialized player in the disposable ureteroscope market. The company offers disposable ureteroscopic solutions designed to complement its lithotripsy and minimally invasive urology portfolio.

The disposable ureteroscope market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Flexible ureteroscope
• Rigid ureteroscope

Market, By Application

• Urolithiasis
• Urethral stricture
• Kidney cancer
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE